Supramolecular self-assemblies of H6/doxorubicin reverse P-gp-mediated multidrug resistance in breast cancer
European Journal of Pharmaceutics and Biopharmaceutics · 2026-08 · 225 · 115102
DOI: 10.1016/j.ejpb.2026.115102 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026-08. Verfasst von Qingquan Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation…. Hauptthemen laut MEDLINE: Doxorubicin, Drug Resistance, Neoplasm, Drug Resistance, Multiple, Breast Neoplasms. Die Arbeit nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Yantai University, Taishan Scholar Project of Shandong Province.
Abstract (Originalsprache)
Tumor multidrug resistance (MDR) remains a major cause of chemotherapy failure. Inhibiting the P-glycoprotein (P-gp)-mediated excessive efflux of chemotherapeutic drugs represent an effective strategy to overcome MDR. Conventional P-gp inhibitors are limited in clinical use due to systemic toxicity and risks of normal tissue dysfunction. In this study, we constructed a self-assembled system based on H6, the α-hederagenin derivative with potent MDR reversal activity, and the chemotherapeutic agent doxorubicin (DOX). Guided by the CREKA peptide, this system specifically targets fibronectin in tumor tissues, thereby enhancing drug accumulation at the lesion site. The combination therapy of H6 and DOX exhibited a combination index (CI) of 0.16 (CI < 1), indicating strong synergistic effects. Both in vitro and in vivo experiments demonstrated that H6 interferes with ATP production and effectively inhibits P-gp efflux function. In a breast cancer MDR model, this strategy achieved a tumor inhibition rate of 81.7%, offering a promising approach to combat tumor MDR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universi…
Förderung
- National Natural Science Foundation of China
- Yantai University
- Taishan Scholar Project of Shandong Province
- Natural Science Foundation of Shandong Province
Zitieren
APA
Sun, Q., Wei, Y., Sun, B., Jiang, Q., Chen, D., Bi, Y., & Chu, Y. (2026). Supramolecular self-assemblies of H6/doxorubicin reverse P-gp-mediated multidrug resistance in breast cancer. European Journal of Pharmaceutics and Biopharmaceutics, 225, 115102. https://doi.org/10.1016/j.ejpb.2026.115102
Vancouver
Sun Q, Wei Y, Sun B, Jiang Q, Chen D, Bi Y, et al. Supramolecular self-assemblies of H6/doxorubicin reverse P-gp-mediated multidrug resistance in breast cancer. European Journal of Pharmaceutics and Biopharmaceutics. 2026;225:115102. doi:10.1016/j.ejpb.2026.115102
BibTeX
@article{Sun2026,
author = {Sun, Qingquan and Wei, Yan and Sun, Baoyuan and Jiang, Qian and Chen, Daquan and Bi, Yi and Chu, Yongchao},
title = {Supramolecular self-assemblies of H6/doxorubicin reverse P-gp-mediated multidrug resistance in breast cancer},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2026},
volume = {225},
pages = {115102},
doi = {10.1016/j.ejpb.2026.115102}
}
EUVIMED